UCLA Jonsson Comprehensive Cancer Center
@UCLAHealthJCCC
Followers
232
Following
393
Media
31
Statuses
295
Official account for the UCLA Jonsson Comprehensive Cancer Center, a leader in cancer care, research and education.
Los Angeles, CA
Joined August 2024
RT @TheFocalTC: “This study offers some of the strongest evidence yet that active surveillance, when guided by modern imaging and minimally….
0
1
0
RT @OncLive: ICYMI: @DrKEMcCann of @UCLAHealth discusses the need to reach consensus on the potential role of vepdegestrant for ER+/HER2-ne….
0
1
0
Congratulations to Dr. Roger Lo on receiving a $1M grant from the @TheVFoundation! He's working to prevent cancer relapse in patients with advanced melanoma by targeting drug resistance before it takes root. Read more about the award:
0
0
2
In the Journal of Clinical Pathways, @UCLAHealth breast surgeon @DrNimmiKapoor discusses the patient-centered benefits of surgeon-performed tumor localization and why she’s pushing for ultrasound training in breast surgery. Read the interview:
0
1
3
RT @HemOncToday: 🖥️ AI may help radiologists detect interval #breastcancer in mammograms that would have been labeled noncancerous. However….
0
1
0
RT @DrNimmiKapoor: Surgeon-Performed Localization and the Push for Ultrasound Training in Modern Breast Cancer Treatment .
0
3
0
A new study led by @VashKurdistani has uncovered a surprising survival strategy in cells that may help explain how MYC-driven cancers survive and grow despite limited resources. Learn more about the findings:
0
4
10
RT @UCLA: The algorithm unlocks the full potential of proteogenomics by overcoming a key challenge in linking genetic mutations to protein-….
0
3
0
RT @HemOncToday: 💻 AI could help radiologists identify hard-to-detect signs and catch interval #breastcancer earlier. 🗨️ “It shows some pr….
0
1
0
Congratulations to @davidulmert on receiving the Hero Award from @AgentsMIB! The grant will support his work to develop and refine a novel radioimmunotherapy for osteosarcoma, a rare and aggressive form of bone cancer.
1
0
5
RT @OncLive: LUMINOSITY Data Continue to Highlight Utility of Telisotuzumab Vedotin in c-MET–Overexpressing NSCLC @UCLAHealthJCCC #lcsm #on….
0
4
0
A computational tool described in @NatureBiotech helps uncover previously hidden protein mutations, offering a powerful new approach to developing diagnostic tests & identifying treatment targets for cancer, neurodegenerative diseases & other conditions.
0
6
19
RT @Chenghao_Zhu: Our paper on moPepGen is finally out in Nature Biotechnology!.moPepGen is a fast graph-based tool for systematically pred….
0
4
0
RT @NRGonc: Protocol Activation! NRG-CC015: Harnessing E-Mindfulness Approaches for Living After Breast Cancer (HEAL-ABC). This trial is av….
0
1
0
RT @UCLA: Jung, who will deliver UCLA’s 130th Faculty Research Lecture, explains how he developed cancer-fighting drugs. .
0
4
0
RT @OncLive: WATCH 📺: Jonathan W. Goldman, MD, of @UCLAHealthJCCC, discusses the role of telisotuzumab vedotin for the treatment of locally….
0
2
0
RT @OncLive: Generic Eltrombopag Expands Access and Flexibility in ITP and Severe Aplastic Anemia @UCLAHealthJCCC #oncology .
0
2
0